Progress in global COVID-19 vaccine development and vaccination strategies

WU Yu; LIU Jue; LIU Min; LIANG Wannian

doi:10.16462/j.cnki.zhjbkz.2023.08.014

Volume 27 Issue 8

Aug. 2023

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2023 > 27(8): 955-962

WU Yu, LIU Jue, LIU Min, LIANG Wannian. Progress in global COVID-19 vaccine development and vaccination strategies[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(8): 955-962. doi: 10.16462/j.cnki.zhjbkz.2023.08.014

Citation:

WU Yu, LIU Jue, LIU Min, LIANG Wannian. Progress in global COVID-19 vaccine development and vaccination strategies[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(8): 955-962. doi: 10.16462/j.cnki.zhjbkz.2023.08.014

Citation:

PDF( 862 KB)

Progress in global COVID-19 vaccine development and vaccination strategies

doi: 10.16462/j.cnki.zhjbkz.2023.08.014

WU Yu¹,
LIU Jue¹,
LIU Min^{1
,
,},
LIANG Wannian^{2
,
,}

1.
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China
2.
Vanke School of Public Health, Tsinghua University, Beijing 100084, China

Funds:

National Key Research and Development Project of China 2021ZD0114104

National Key Research and Development Project of China 2021ZD0114105

National Key Research and Development Project of China 2021ZD0114101

National Natural Science Foundation of China 71934002

National Natural Science Foundation of China 72122001

More Information

Corresponding author: LIU Min, E-mail: liumin@bjmu.edu.cn; LIANG Wannian, E-mail: liangwn@tsinghua.edu.cn
Received Date: 2023-06-08
Rev Recd Date: 2023-07-10

Available Online: 2023-09-02

Publish Date: 2023-08-10

Abstract

Abstract

On May 5, 2023, the World Health Organization declared that the outbreak of COVID-19 no longer constitutes a public health emergency of international concern. The global epidemic is relatively stable, but countries should not relax their vigilance against the novel coronavirus. Vaccination against COVID-19 remains an effective means of prevention. This study mainly makes a comparative analysis of the current progress of global COVID-19 vaccine research and development and the adjustment of vaccination strategies in different countries, combined with the latest guidance recommended by the World Health Organization on COVID-19 vaccine vaccination strategies, analyzes and discusses the inspiration of global COVID-19 vaccine research and development and national vaccination strategies for China, and puts forward targeted vaccination recommendations suitable for China's national conditions.
- COVID-19,
- vaccine,
- vaccination strategies,
- World Health Organization

FullText(HTML)

References(25)

References

[1]	WHO. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic[EB/OL]. (2023-05-05)[2023-06-07]. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.
[2]	WHO. WHO Coronavirus (COVID-19) Dashboard[EB/OL]. (2023-06-01)[2023-06-02]. https://covid19.who.int/.
[3]	Our world in data. Coronavirus (COVID-19) Vaccinations[EB/OL]. (2023-06-01)[2023-06-02]. https://ourworldindata.org/covid-vaccinations.
[4]	WHO. COVID-19 vaccine tracker and landscape[EB/OL]. (2023-03-30)[2023-06-02]. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
[5]	张旋旋, 佘广彪, 刘晓雅, 等. 新冠病毒蛋白亚单位疫苗研究进展[J]. 中国医药导刊, 2022, 24(5): 434-438. https://www.cnki.com.cn/Article/CJFDTOTAL-DKYY202205001.htm Zhang XX, She GB, Liu XY, et al. Research progress of SARS-CoV-2 protein subunit vaccine[J]. Chin J Med Guide, 2022, 24(5): 434-438. https://www.cnki.com.cn/Article/CJFDTOTAL-DKYY202205001.htm
[6]	WHO. WHO lists two additional COVID-19 vaccines for Emergency use and COVAX roll-out[EB/OL]. (2021-02-15)[2023-06-02]. https://www.who.int/news/item/15-02-2021-who-lists-two-additional-covid-19-vaccines-for-emergency-use-and-covax-roll-out.
[7]	WHO. COVID-19 Vaccines with WHO Emergency Use Listing[EB/OL]. (2022-06-16)[2023-07-03]. https://extranet.who.int/pqweb/vaccines/vaccinescovid-19-vaccine-eul-issued.
[8]	预防界. 应对变异、广谱多价, 专家共话新冠病毒疫苗研发新进展[EB/OL]. (2023-04-19)[2023-06-02]. https://new.qq.com/rain/a/20230419A012SF00. The prevention community. In response to variation, broad spectrum and multi-price, experts shared new progress in the development of COVID-19 vaccine[EB/OL]. (2023-04-19)[2023-06-02]. https://new.qq.com/rain/a/20230419A012SF00.
[9]	屠博文, 王楠, 董泽丰, 等. 新冠病毒Omicron XBB. 1.5和XBB. 1.9及其亚分支变异株流行情况及相关认知进展[J]. 江苏预防医学, 2023, 34(02): 119-122. DOI: 10.13668/j.issn.1006-9070.2023.02.001. Tu BW, Wang N, Dong ZF, et al. Prevalence of Omicron XBB. 1.5 and XBB. 1.9 and their subbranch variants and related cognitive progress of novel coronavirus[J]. Jiangsu preventive medicine, 2023, 34(02): 119-122. DOI: 10.13668/j.issn.1006-9070.2023.02.001.
[10]	Karyakarte RP, Das R, Dudhate S, et al. Clinical characteristics and outcomes of laboratory-confirmed SARS-CoV-2 cases infected with omicron subvariants and the XBB recombinant variant[J]. Cureus, 2023, 15(2): e35261. DOI: 10.7759/cureus.35261.
[11]	WHO. SAGE updates COVID-19 vaccination guidance[EB/OL]. (2023-04-19)[2023-06-02]. https://www.who.int/news/item/28-03-2023-sage-updates-covid-19-vaccination-guidance.
[12]	WHO. Statement on the antigen composition of COVID-19 vaccines[EB/OL]. (2023-05-18)[2023-06-02]. https://www.who.int/news/item/18-05-2023-statement-on-the-antigen-composition-of-covid-19-vaccines.
[13]	WHO. Stay Up to Date with COVID-19 Vaccines[EB/OL]. (2023-06-01)[2023-06-02]. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html.
[14]	ABC News. FDA proposes most Americans receive one annual COVID vaccine, similar to flu[EB/OL]. (2023-01-26)[2023-06-02]. https://abcnews.go.com/Health/fda-proposes-americans-receive-annual-covid-vaccine-similar/story?id=96617332.
[15]	White House. The Biden-Harris Administration Will End COVID-19 Vaccination Requirements for Federal Employees, Contractors, International Travelers, Head Start Educators, and CMS-Certified Facilities[EB/OL]. (2023-05-01)[2023-06-02]. https://www.whitehouse.gov/briefing-room/statements-releases/2023/05/01/the-biden-administration-will-end-covid-19-vaccination-requirements-for-federal-employees-contractors-international-travelers-head-start-educators-and-cms-certified-facilities/.
[16]	White House. A Proclamation on Revoking the Air Travel COVID-19 Vaccination Requirement[EB/OL]. (2023-05-09)[2023-06-02]. https://www.whitehouse.gov/briefing-room/presidential-actions/2023/05/09/a-proclamation-on-revoking-the-air-travel-covid-19-vaccination-requirement/.
[17]	NHS. About COVID-19 vaccination[EB/OL]. (2023-03-21)[2023-06-02]. https://www.nhs.uk/conditions/covid-19/covid-19-vaccination/about-covid-19-vaccination/.
[18]	UK Health Security Agency. JCVI advises an autumn COVID-19 vaccine booster[EB/OL]. (2023-01-25)[2023-06-02]. https://www.gov.uk/government/news/jcvi-advises-an-autumn-covid-19-vaccine-booster.
[19]	日本驻华大使馆. 新冠病毒疫情(前往日本所需手续)(4月28日更新)[EB/OL]. (2023-04-28)[2023-06-02]. https://www.cn.emb-japan.go.jp/itpr_zh/00_000485_00186.html. Japanese Embassy in China. COVID-19 (Procedures Required for Travel to Japan) (Updated on April 28)[EB/OL]. (2023-04-28)[2023-06-02]. https://www.cn.emb-japan.go.jp/itpr_zh/00_000485_00186.html.
[20]	界面新闻. 日本将引进针对XBB变异株的新冠疫苗, 用于9月起秋季接种[EB/OL]. (2023-06-17)[2023-07-02]. https://www.jiemian.com/article/9595613.html. Interface news. Japan will introduce a novel coronavirus vaccine against the XBB variant for autumn vaccination starting in September[EB/OL]. (2023-06-17)[2023-07-02]. https://www.jiemian.com/article/9595613.html.
[21]	国家卫生健康委员会. 关于印发应对近期新冠病毒感染疫情疫苗接种工作方案的通知[EB/OL]. (2023-04-10)[2023-06-02]. https://www.gov.cn/lianbo/2023-04/10/content_5750733.htm. National Health Commission. Notice on the issuance of the work plan for vaccination in response to the recent outbreak of novel coronavirus infection[EB/OL]. (2023-04-10)[2023-06-02]. https://www.gov.cn/lianbo/2023-04/10/content_5750733.htm.
[22]	北京市疾病预防控制中心. 2023年第19周疫情周报[EB/OL]. (2023-05-18)[2023-06-02]. https://www.bjcdc.org/cdcmodule/jkdt/yqbb/2023/82468.shtml. Beijing Center for Disease Control and Prevention. Weekly Epidemic Report of the 19th week of 2023[EB/OL]. (2023-05-18)[2023-06-02]. https://www.bjcdc.org/cdcmodule/jkdt/yqbb/2023/82468.shtml.
[23]	澎湃新闻. 中疾控: 我国新冠病毒主要流行株已变为XBB系列变异株, 致病力无明显变化[EB/OL]. (2023-05-08)[2023-06-02]. https://www.thepaper.cn/newsDetail_forward_22998689. Pengpai News. Chinese Center for Disease Control and Prevention: The main circulating strain of the novel coronavirus in China has changed into the XBB series variant strain, and the pathogenicity has not changed significantly[EB/OL]. (2023-05-08)[2023-06-02]. https://www.thepaper.cn/newsDetail_forward_22998689.
[24]	第一财经. 继续免费还是部分自费?专家建议优化中国新冠疫苗政策[EB/OL]. (2023-05-08)[2023-06-02]. https://finance.eastmoney.com/a/202305082714859920.html. China Business News. Remain free or partially self-financed? Experts suggest improving China's COVID-19 vaccine policy[EB/OL]. (2023-05-08)[2023-06-02]. https://finance.eastmoney.com/a/202305082714859920.html.
[25]	澳门特别行政区政府新闻局. 参考世卫及各地卫生部门最新建议本澳将调整新冠疫苗接种策略[EB/OL]. (2023-04-05)[2023-06-02]. https://www.gcs.gov.mo/detail/zh-hans/N23DE2adiv. Information Bureau of the Government of the Macao Special Administrative Region. In light of the latest advice from WHO and local health authorities, Australia will adjust its COVID-19 vaccination strategy[EB/OL]. (2023-04-05)[2023-06-02]. https://www.gcs.gov.mo/detail/zh-hans/N23DE2adiv.